BSE: SOLARA - Solara Active Pharma Sciences Limited

Rentabilität für sechs Monate: -35.98%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Solara Active Pharma Sciences Limited


Über das Unternehmen Solara Active Pharma Sciences Limited

Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India.

weitere details
The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.

ISIN INE624Z01016
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.4382
Дивиденд ао 3.04
Сайт https://www.solara.co.in
Цена ао 512.45
Preisänderung pro Tag: +0.6775% (509.25)
Preisänderung pro Woche: -3.37% (530.6)
Preisänderung pro Monat: +4.1% (492.5)
Preisänderung über 3 Monate: -24.07% (675.25)
Preisänderung über sechs Monate: -35.98% (800.8)
Preisänderung pro Jahr: +34.14% (382.2)
Preisänderung über 3 Jahre: -20.12% (641.83)
Preisänderung über 5 Jahre: -1.91% (522.708)
Preisänderung seit Jahresbeginn: -26.87% (701.1)

Unterschätzung

Name Bedeutung Grad
P/S 1.2 9
P/BV 1.59 8
P/E 0 0
EV/EBITDA 14.19 7
Gesamt: 5.25

Effizienz

Name Bedeutung Grad
ROA, % -21.63 0
ROE, % -46.55 0
Gesamt: 0.8333

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.6 6
Gesamt: 1.33

Pflicht

Name Bedeutung Grad
Debt/EBITDA 6.39 0
Gesamt: 5.6

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -2.31 0
Rentabilität Ebitda, % -43.46 0
Rentabilität EPS, % -468.02 0
Gesamt: 0



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Poorvank Purohit MD, CEO & Director N/A 1979 (46 Jahre)
Mr. Mohan Muthunarayanan COO & Executive Director N/A
Mr. Suddapalli Murali Krishna Company Secretary, Compliance Officer & Chief Investor Relations Officer N/A
Mr. Arun Kumar Pillai B.Com. Founder & Non-Executive Director N/A 1961 (64 Jahr)
Mr. V. Sundara Moorthy Chief Quality Officer N/A
Mr. Arun Kumar Baskaran Chief Financial Officer N/A
Dr. Hero Velladurai Chief Scientific Officer N/A

Adresse: India, Chennai, Admin Block 27 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.solara.co.in